Passumpsic Savings Bank Sells 119 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Passumpsic Savings Bank trimmed its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 1.1% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,249 shares of the biotechnology company’s stock after selling 119 shares during the quarter. Axon Enterprise makes up about 2.7% of Passumpsic Savings Bank’s portfolio, making the stock its 6th largest holding. Passumpsic Savings Bank’s holdings in Axon Enterprise were worth $4,096,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also added to or reduced their stakes in AXON. Neo Ivy Capital Management acquired a new position in shares of Axon Enterprise during the third quarter worth $2,696,000. Coldstream Capital Management Inc. increased its holdings in Axon Enterprise by 254.2% in the 3rd quarter. Coldstream Capital Management Inc. now owns 7,524 shares of the biotechnology company’s stock worth $3,032,000 after purchasing an additional 5,400 shares in the last quarter. Synergy Financial Group LTD raised its position in Axon Enterprise by 4.9% in the third quarter. Synergy Financial Group LTD now owns 747 shares of the biotechnology company’s stock valued at $299,000 after purchasing an additional 35 shares during the last quarter. Geode Capital Management LLC boosted its stake in shares of Axon Enterprise by 2.0% during the third quarter. Geode Capital Management LLC now owns 1,782,828 shares of the biotechnology company’s stock valued at $710,103,000 after purchasing an additional 35,320 shares in the last quarter. Finally, Prestige Wealth Management Group LLC grew its holdings in shares of Axon Enterprise by 115.8% during the third quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock worth $33,000 after purchasing an additional 44 shares during the last quarter. Institutional investors own 79.08% of the company’s stock.

Axon Enterprise Stock Performance

NASDAQ AXON opened at $637.45 on Wednesday. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The company has a fifty day moving average price of $525.87 and a 200-day moving average price of $398.80. Axon Enterprise, Inc. has a 1 year low of $235.33 and a 1 year high of $698.67. The firm has a market cap of $48.61 billion, a price-to-earnings ratio of 164.72, a PEG ratio of 15.13 and a beta of 1.01.

Insider Buying and Selling at Axon Enterprise

In related news, CFO Brittany Bagley sold 4,338 shares of the firm’s stock in a transaction dated Thursday, September 12th. The shares were sold at an average price of $378.95, for a total transaction of $1,643,885.10. Following the completion of the sale, the chief financial officer now owns 98,825 shares in the company, valued at approximately $37,449,733.75. This trade represents a 4.20 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Patrick W. Smith sold 47,314 shares of the business’s stock in a transaction dated Tuesday, October 1st. The shares were sold at an average price of $400.07, for a total transaction of $18,928,911.98. Following the completion of the transaction, the chief executive officer now owns 2,983,802 shares in the company, valued at approximately $1,193,729,666.14. The trade was a 1.56 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 103,928 shares of company stock worth $50,820,792. Insiders own 5.70% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on AXON. JMP Securities raised their price objective on shares of Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a report on Thursday, October 31st. Needham & Company LLC lifted their price objective on Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a research note on Friday, November 8th. Northland Securities increased their price objective on shares of Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research report on Monday, November 11th. Morgan Stanley raised Axon Enterprise from an “equal weight” rating to an “overweight” rating and lifted their price objective for the stock from $500.00 to $700.00 in a research report on Tuesday, December 3rd. Finally, Robert W. Baird raised their price objective on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. One research analyst has rated the stock with a hold rating and thirteen have given a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $488.67.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.